Genzyme, Janssen, Merck-Serono, Novartis, Roche, Sanofi-Aventis, Viela Bio and Teva Pharmaceuticals. Data Safety Monitoring Board for Parexel and UCB Biopharma, Relapse Adjudication Committee for ...

The Cambridge, Massachusetts-based firm was first set ... it has a broad partnership with experienced rare disease company Genzyme to develop and commercialise its drugs in the rest of the world.

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to improve drug development by speeding up clinical trial recruitment.

Sanofi (Symbol: SNY) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

Under the new structure, due to come into effect next January, Sanofi's cancer and immunology pipeline with now sit alongside subsidiary Genzyme's rare disease and multiple sclerosis (MS ...

Sanofi India Limited (Previously known as Aventis Pharma Limited) was incorporated in May 1956. The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11 2012. The ...

In addition to voting in the presidential contest between Republican Donald Trump and Democrat Kamala Harris, voters in Massachusetts will cast ballots for the state’s nine congressional districts.

Terms may apply to offers listed on this page. If you're looking to buy a home in Massachusetts, you'll want to find the best mortgage rates available. It's a good idea to shop around for a home ...

Future Oncol. 2010;6(1):55-74. Stimulates proliferation, migration and invasiveness of breast cancer cells SPRYCEL Phase III trials recruiting for CML Phase I/II (+ZA) recruit Important for proper ...

Future Oncol. 2010;6(1):55-74. Disruption of CXCR4 signaling in combination with traditional cytotoxic chemotherapies, particularly in the adjuvant setting, represents an exciting strategy for ...

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 14,385.85 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...